Itamar Livnat

Itamar Livnat practices at Los Angeles General Medical Center in Los Angeles, California, part of County of Los Angeles.

Itamar Livnat's NPI, 1770042897, was assigned on March 18, 2019. Itamar Livnat graduated from University of Illinois College of Medicine - Chicago in 2014. Itamar Livnat holds California license A180711.

Itamar Livnat's primary practice is Los Angeles General Medical Center, at 2051 Marengo St, Room C2K100, Los Angeles, CA 90033 in Los Angeles County. The practice phone is (323) 226-2800.

Itamar Livnat's primary practice is Los Angeles General Medical Center in Los Angeles, California, part of County of Los Angeles. Itamar Livnat is also affiliated with Zuckerberg San Francisco General Hospital and Trauma Center. The medical group on file is UCSF Medical Group. Dmand AI also links Itamar Livnat to 5 more medical groups, each named with a free account. Itamar Livnat's employer is on file too: a hospital.

Dmand AI tracks the electronic health record (EHR) system at each site where Itamar Livnat practices, 2 sites in all. Vendor and product names are available with a free account.

Ophthalmology is Itamar Livnat's primary specialty in the NPI Registry, under taxonomy code 207W00000X. Itamar Livnat is licensed in California.

CMS data shows 175 Medicare services from Itamar Livnat across 5 procedure codes in 2024, for 97 Medicare patients. Medicare paid $10,750 for them. Every service was in an office.

CMS counts 97 Medicare patients who saw Itamar Livnat in 2024. The largest group is 65 to 74, with 52 patients. 71% of them have high cholesterol, and 63% have high blood pressure. 34% are also on Medicaid. Their average risk score is 1.41, where 1.00 is the Medicare average.

Across all payers, Dmand AI patient panel data puts Itamar Livnat's median patient age at 65, with 57% women.

In 2024, Itamar Livnat wrote 284 Medicare Part D claims for 81 patients. 64% of them were for generic drugs. CMS names the drug for 156 of them, across 7 drugs with 11 or more claims each, at $8,740 in total drug cost. In 2023, CMS named 31 claims across 2 drugs.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 100 out of 100 for Itamar Livnat for performance year 2024, reported as part of a group.

Dmand AI links 7 papers to Itamar Livnat, published from 2013 to 2025. 2013 was the busiest year, with 2. The most frequent topics are Aplysia, Behavior, Animal and Neuropeptides. Itamar Livnat's most frequent co-authors are Andrew Wellesley Browne, MD, PhD, John Doan, MD and John Alexander Gonzales, MD.

CMS Open Payments shows 53 general payments to Itamar Livnat from 8 drug and device companies from 2021 to 2025. Food and beverage make up the largest share, 56% of the total. Bausch & Lomb Americas Inc. paid the most, $2,029.

Itamar Livnat graduated from University of Illinois College of Medicine - Chicago in 2014.

Itamar Livnat is in network with 3 carriers, including Blue Cross Blue Shield of Massachusetts, HCSC and Molina. Medicare plans come from the most carriers, 3. Check the plan with the practice before a visit.